{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T01:46:22Z","timestamp":1743126382924,"version":"3.40.3"},"publisher-location":"Cham","reference-count":64,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783031368042"},{"type":"electronic","value":"9783031368059"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-36805-9_5","type":"book-chapter","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T23:03:04Z","timestamp":1688079784000},"page":"67-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational Studies Unveiling the Mechanism of Action of Selected Pt-, Te-, Au-, Rh-, Ru-Based Drugs"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-5331","authenticated-orcid":false,"given":"Iogann","family":"Tolbatov","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8311-8172","authenticated-orcid":false,"given":"Alessandro","family":"Marrone","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"issue":"8","key":"5_CR1","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1021\/cr400460s","volume":"114","author":"KD Mjos","year":"2014","unstructured":"Mjos, K.D., Orvig, C.: Metallodrugs in medicinal inorganic chemistry. Chem. Rev. 114(8), 4540\u20134563 (2014). https:\/\/doi.org\/10.1021\/cr400460s","journal-title":"Chem. Rev."},{"issue":"48","key":"5_CR2","doi-asserted-by":"publisher","first-page":"12888","DOI":"10.1039\/D0SC04082G","volume":"11","author":"EJ Anthony","year":"2020","unstructured":"Anthony, E.J., Bolitho, E.M., Bridgewater, H.E., Carter, O.W., Donnelly, J.M., Imberti, C., et al.: Metallodrugs are unique: opportunities and challenges of discovery and development. Chem. Sci. 11(48), 12888\u201312917 (2020). https:\/\/doi.org\/10.1039\/D0SC04082G","journal-title":"Chem. Sci."},{"key":"5_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2021.214104","volume":"445","author":"I Yousuf","year":"2021","unstructured":"Yousuf, I., Bashir, M., Arjmand, F., Tabassum, S.: Advancement of metal compounds as therapeutic and diagnostic metallodrugs: current frontiers and future perspectives. Coord. Chem. Rev. 445, 214104 (2021). https:\/\/doi.org\/10.1016\/j.ccr.2021.214104","journal-title":"Coord. Chem. Rev."},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ica.2016.01.006","volume":"444","author":"M Zaki","year":"2016","unstructured":"Zaki, M., Arjmand, F., Tabassum, S.: Current and future potential of metallo drugs: revisiting DNA-binding of metal containing molecules and their diverse mechanism of action. Inorg. Chim. Acta 444, 1\u201322 (2016). https:\/\/doi.org\/10.1016\/j.ica.2016.01.006","journal-title":"Inorg. Chim. Acta"},{"issue":"23\u201324","key":"5_CR5","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.drudis.2010.10.005","volume":"15","author":"M Navarro","year":"2010","unstructured":"Navarro, M., Gabbiani, C., Messori, L., Gambino, D.: Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives. Drug Discov. Today 15(23\u201324), 1070\u20131078 (2010). https:\/\/doi.org\/10.1016\/j.drudis.2010.10.005","journal-title":"Drug Discov. Today"},{"key":"5_CR6","unstructured":"Riddell, I., Lippard, S.J., Brabec, V., Kasparkova, J., Menon, V., Farrell, N.P., et al.: Metallo-drugs: development and action of anticancer agents, vol. 18. Walter de Gruyter GmbH & Co KG, Wustermark (2018)"},{"issue":"12","key":"5_CR7","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.3390\/biom11121858","volume":"11","author":"D Cirri","year":"2021","unstructured":"Cirri, D., Marzo, T., Tolbatov, I., Marrone, A., Saladini, F., Vicenti, I., et al.: In vitro anti-SARS-CoV-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study. Biomolecules 11(12), 1858 (2021). https:\/\/doi.org\/10.3390\/biom11121858","journal-title":"Biomolecules"},{"key":"5_CR8","series-title":"Lecture Notes in Computer Science","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/978-3-030-87016-4_30","volume-title":"Computational Science and Its Applications \u2013 ICCSA 2021","author":"I Tolbatov","year":"2021","unstructured":"Tolbatov, I., Marrone, A., Paciotti, R., Re, N., Coletti, C.: Multilayered modelling of the metallation of biological targets. In: Gervasi, O., et al. (eds.) ICCSA 2021. LNCS, vol. 12958, pp. 398\u2013412. Springer, Cham (2021). https:\/\/doi.org\/10.1007\/978-3-030-87016-4_30"},{"issue":"22","key":"5_CR9","doi-asserted-by":"publisher","first-page":"11985","DOI":"10.1021\/acs.analchem.7b02211","volume":"89","author":"RF Lee","year":"2017","unstructured":"Lee, R.F., Menin, L., Patiny, L., Ortiz, D., Dyson, P.J.: Versatile tool for the analysis of metal\u2013protein interactions reveals the promiscuity of metallodrug\u2013protein interactions. Anal. Chem. 89(22), 11985\u201311989 (2017). https:\/\/doi.org\/10.1021\/acs.analchem.7b02211","journal-title":"Anal. Chem."},{"key":"5_CR10","doi-asserted-by":"publisher","unstructured":"Miodragovic\u0301, D., et al.: Arsenoplatin-1 is a dual pharmacophore anticancer agent. J. Am. Chem. Soc. 141(16), 6453\u20136457 (2019). https:\/\/doi.org\/10.1021\/jacs.8b13681","DOI":"10.1021\/jacs.8b13681"},{"issue":"41","key":"5_CR11","doi-asserted-by":"publisher","first-page":"10749","DOI":"10.1002\/anie.201303251","volume":"52","author":"\u00d0U Miodragovi\u0107","year":"2013","unstructured":"Miodragovi\u0107, \u00d0.U., Quentzel, J.A., Kurutz, J.W., Stern, C.L., Ahn, R.W., Kandela, I., et al.: Robust structure and reactivity of aqueous arsenous acid\u2013platinum (II) anticancer complexes. Angew. Chem. Int. Ed. 52(41), 10749\u201310752 (2013). https:\/\/doi.org\/10.1002\/anie.201303251","journal-title":"Angew. Chem. Int. Ed."},{"key":"5_CR12","doi-asserted-by":"publisher","unstructured":"Miodragovi\u0107, \u00d0., Swindell, E.P., Waxali, Z.S., Bogachkov, A., O'Halloran, T.V.: Beyond cisplatin: Combination therapy with arsenic trioxide. Inorg. Chim. Acta 119030 (2019). https:\/\/doi.org\/10.1016\/j.ica.2019.119030","DOI":"10.1016\/j.ica.2019.119030"},{"issue":"7","key":"5_CR13","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1039\/d0qi01165g","volume":"8","author":"A Parise","year":"2021","unstructured":"Parise, A., Russo, N., Marino, T.: The platination mechanism of RNase a by arsenoplatin: Insight from the theoretical study. Inorg. Chem. Front. 8(7), 1795\u20131803 (2021). https:\/\/doi.org\/10.1039\/d0qi01165g","journal-title":"Inorg. Chem. Front."},{"issue":"2","key":"5_CR14","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1039\/c6cp06179f","volume":"19","author":"T Marino","year":"2017","unstructured":"Marino, T., Parise, A., Russo, N.: The role of arsenic in the hydrolysis and DNA metalation processes in an arsenous acid\u2013platinum (II) anticancer complex. Phys. Chem. Chem. Phys. 19(2), 1328\u20131334 (2017). https:\/\/doi.org\/10.1039\/c6cp06179f","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"8","key":"5_CR15","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1021\/ic500360f","volume":"53","author":"L Messori","year":"2014","unstructured":"Messori, L., Merlino, A.: Cisplatin binding to proteins: molecular structure of the ribonuclease a adduct. Inorg. Chem. 53(8), 3929\u20133931 (2014). https:\/\/doi.org\/10.1021\/ic500360f","journal-title":"Inorg. Chem."},{"issue":"7","key":"5_CR16","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1021\/acs.inorgchem.1c03732","volume":"61","author":"I Tolbatov","year":"2022","unstructured":"Tolbatov, I., Cirri, D., Tarchi, M., Marzo, T., Coletti, C., Marrone, A., et al.: Reactions of arsenoplatin-1 with protein targets: a combined experimental and theoretical study. Inorg. Chem. 61(7), 3240\u20133248 (2022). https:\/\/doi.org\/10.1021\/acs.inorgchem.1c03732","journal-title":"Inorg. Chem."},{"key":"5_CR17","first-page":"145","volume":"8","author":"BS Sekhon","year":"2013","unstructured":"Sekhon, B.S.: Metalloid compounds as drugs. Res. Pharm. Sci. 8, 145\u2013158 (2013)","journal-title":"Res. Pharm. Sci."},{"issue":"12","key":"5_CR18","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.autrev.2014.08.003","volume":"13","author":"G Halpert","year":"2014","unstructured":"Halpert, G., Sredni, B.: The effect of the novel tellurium compound AS101 on autoimmune diseases. Autoimmun. Rev. 13(12), 1230\u20131235 (2014). https:\/\/doi.org\/10.1016\/j.autrev.2014.08.003","journal-title":"Autoimmun. Rev."},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1136\/bjophthalmol-2012-301962","volume":"97","author":"D Ling","year":"2013","unstructured":"Ling, D., Liu, B., Jawad, S., Thompson, I.A., Nagineni, C.N., Dailey, J., et al.: The tellurium redox immunomodulating compound AS101 inhibits IL-1\u03b2-activated inflammation in the human retinal pigment epithelium. Br. J. Ophthalmol. 97, 934\u2013938 (2013). https:\/\/doi.org\/10.1136\/bjophthalmol-2012-301962","journal-title":"Br. J. Ophthalmol."},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1021\/IC971456T","volume":"37","author":"A Albeck","year":"1998","unstructured":"Albeck, A., Weitman, H., Sredni, B., Albeck, M.: Tellurium compounds: selective inhibition of cysteine proteases and model reaction with thiols. Inorg. Chem. 37, 1704\u20131712 (1998). https:\/\/doi.org\/10.1021\/IC971456T","journal-title":"Inorg. Chem."},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1021\/acsomega.7b00628","volume":"2","author":"CR Princival","year":"2017","unstructured":"Princival, C.R., Archilha, M.V.L.R., Dos Santos, A.A., Franco, M.P., Braga, A.A.C., Rodrigues-Oliveira, A.F., et al.: Stability study of hypervalent tellurium compounds in aqueous solutions. ACS Omega 2, 4431\u20134439 (2017). https:\/\/doi.org\/10.1021\/acsomega.7b00628","journal-title":"ACS Omega"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1158\/0008-5472.can-13-2159","volume":"74","author":"A Layani-Bazar","year":"2014","unstructured":"Layani-Bazar, A., Skornick, I., Berrebi, A., Pauker, M.H., Noy, E., Silberman, A., et al.: Redox modulation of adjacent thiols in vla-4 by as101 converts myeloid leukemia cells from a drug-resistant to drug-sensitive state. Cancer Res. 74, 3092\u20133103 (2014). https:\/\/doi.org\/10.1158\/0008-5472.can-13-2159","journal-title":"Cancer Res."},{"issue":"14","key":"5_CR23","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.3390\/ijms23147505","volume":"23","author":"L Chiaverini","year":"2022","unstructured":"Chiaverini, L., Cirri, D., Tolbatov, I., Corsi, F., Piano, I., Marrone, A., et al.: Medicinal hypervalent tellurium prodrugs bearing different ligands: a comparative study of the chemical profiles of AS101 and its halido replaced analogues. Int. J. Mol. Sci. 23(14), 7505 (2022). https:\/\/doi.org\/10.3390\/ijms23147505","journal-title":"Int. J. Mol. Sci."},{"key":"5_CR24","first-page":"279","volume":"41","author":"L Messori","year":"2004","unstructured":"Messori, L., Marcon, G.: Gold complexes in the treatment of rheumatoid arthritis. Met. Ions Biol. Syst. 41, 279\u2013304 (2004)","journal-title":"Met. Ions Biol. Syst."},{"issue":"11\u201312","key":"5_CR25","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.ccr.2008.12.003","volume":"253","author":"M Navarro","year":"2009","unstructured":"Navarro, M.: Gold complexes as potential anti-parasitic agents. Coord. Chem. Rev. 253(11\u201312), 1619\u20131626 (2009). https:\/\/doi.org\/10.1016\/j.ccr.2008.12.003","journal-title":"Coord. Chem. Rev."},{"key":"5_CR26","doi-asserted-by":"crossref","unstructured":"Casini, A., Sun, R.W.Y., Ott, I.: Medicinal chemistry of gold anticancer metallodrugs. In: Metallo-Drugs: Development and Action of Anticancer Agents, vol. 18, pp. 199\u2013217 (2018)","DOI":"10.1515\/9783110470734-007"},{"issue":"3","key":"5_CR27","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3390\/pharmaceutics15030985","volume":"15","author":"I Tolbatov","year":"2023","unstructured":"Tolbatov, I., Marrone, A.: Auranofin targeting the NDM-1 beta-lactamase: computational insights into the electronic configuration and quasi-tetrahedral coordination of gold ions. Pharmaceutics 15(3), 985 (2023). https:\/\/doi.org\/10.3390\/pharmaceutics15030985","journal-title":"Pharmaceutics"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"108272","DOI":"10.1016\/j.intimp.2021.108272","volume":"101","author":"M Yamashita","year":"2021","unstructured":"Yamashita, M.: Auranofin: Past to Present, and repurposing. Int. Immunopharmacol. 101, 108272 (2021). https:\/\/doi.org\/10.1016\/j.intimp.2021.108272","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"5_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","volume":"15","author":"C Roder","year":"2015","unstructured":"Roder, C., Thomson, M.J.: Auranofin: repurposing an old drug for a golden new age. Drugs R&D 15(1), 13\u201320 (2015). https:\/\/doi.org\/10.1007\/s40268-015-0083-y","journal-title":"Drugs R&D"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"22571","DOI":"10.1038\/srep22571","volume":"6","author":"S Thangamani","year":"2016","unstructured":"Thangamani, S., Mohammad, H., Abushahba, M.F.N., Sobreira, T.J.P., Hedrick, V.E., Paul, L.N., et al.: Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens. Sci. Rep. 6, 22571 (2016). https:\/\/doi.org\/10.1038\/srep22571","journal-title":"Sci. Rep."},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijantimicag.2015.12.016","volume":"47","author":"S Thangamani","year":"2016","unstructured":"Thangamani, S., Mohammad, H., Abushahba, M.F.N., Sobreira, T.J.P., Seleem, M.N.: Repurposing auranofin for the treatment of cutaneous staphylococcal infections. Int. J. Antimicrob. Agents 47, 195\u2013201 (2016). https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.12.016","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"24","key":"5_CR32","doi-asserted-by":"publisher","first-page":"7600","DOI":"10.3390\/molecules26247600","volume":"26","author":"I Tolbatov","year":"2021","unstructured":"Tolbatov, I., Marrone, A., Coletti, C., Re, N.: Computational studies of Au (I) and Au (III) anticancer metallodrugs: a survey. Molecules 26(24), 7600 (2021). https:\/\/doi.org\/10.3390\/molecules26247600","journal-title":"Molecules"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1128\/jb.00164-09","volume":"191","author":"S Jackson-Rosario","year":"2009","unstructured":"Jackson-Rosario, S., Self, W.T.: Inhibition of selenium metabolism in the oral pathogen treponema denticola. J. Bacteriol. 191, 4035\u20134040 (2009). https:\/\/doi.org\/10.1128\/jb.00164-09","journal-title":"J. Bacteriol."},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1002\/cmdc.201800498","volume":"13","author":"T Marzo","year":"2018","unstructured":"Marzo, T., Cirri, D., Pollini, S., Prato, M., Fallani, S., Cassetta, M.I., et al.: Auranofin and its analogues show potent antimicrobial activity against multidrug-resistant pathogens: structure-activity relationships. ChemMedChem 13, 2448\u20132454 (2018). https:\/\/doi.org\/10.1002\/cmdc.201800498","journal-title":"ChemMedChem"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"213905","DOI":"10.1016\/j.ccr.2021.213905","volume":"438","author":"T Gamberi","year":"2021","unstructured":"Gamberi, T., Pratesi, A., Messori, L., Massai, L.: Proteomics as a tool to disclose the cellular and molecular mechanisms of selected anticancer gold compounds. Coord. Chem. Rev. 438, 213905 (2021). https:\/\/doi.org\/10.1016\/j.ccr.2021.213905","journal-title":"Coord. Chem. Rev."},{"issue":"8","key":"5_CR36","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3390\/molecules27082578","volume":"27","author":"L Chiaverini","year":"2022","unstructured":"Chiaverini, L., Pratesi, A., Cirri, D., Nardinocchi, A., Tolbatov, I., Marrone, A., et al.: Anti-staphylococcal activity of the auranofin analogue bearing acetylcysteine in place of the thiosugar: an experimental and theoretical investigation. Molecules 27(8), 2578 (2022). https:\/\/doi.org\/10.3390\/molecules27082578","journal-title":"Molecules"},{"issue":"3","key":"5_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/s1040-8428(01)00222-0","volume":"42","author":"N Katsaros","year":"2002","unstructured":"Katsaros, N., Anagnostopoulou, A.: Rhodium and its compounds as potential agents in cancer treatment. Crit. Rev. Oncol. Hematol. 42(3), 297\u2013308 (2002). https:\/\/doi.org\/10.1016\/s1040-8428(01)00222-0","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"5_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5935\/0103-5053.19940005","volume":"5","author":"MS Nothenberg","year":"1994","unstructured":"Nothenberg, M.S., Zyngier, S.B., Giesbrecht, A.M., Gambardella, M.T.P., Santos, R.H.A., Kimura, E., et al.: Biological activity and crystallographic study of a rhodium propionate-metronidazole adduct. J. Braz. Chem. Soc. 5(1), 23\u201329 (1994)","journal-title":"J. Braz. Chem. Soc."},{"key":"5_CR39","unstructured":"Howard, R.A., Kimball, A.P., Bear, J.L.: Mechanism of action of tetra-\u00b5-carboxylatodirhodium (II) in L1210 tumor suspension culture. Cancer Res. 39(7.1), 2568\u20132573 (1979)"},{"issue":"2","key":"5_CR40","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1107\/s160057751900033x","volume":"26","author":"A Enriquez Garcia","year":"2019","unstructured":"Enriquez Garcia, A., Jalilehvand, F., Niksirat, P.: Reactions of Rh2(CH3COO)4 with thiols and thiolates: a structural study. J. Synchrotron Radiat. 26(2), 450\u2013461 (2019). https:\/\/doi.org\/10.1107\/s160057751900033x","journal-title":"J. Synchrotron Radiat."},{"issue":"20","key":"5_CR41","doi-asserted-by":"publisher","first-page":"12787","DOI":"10.1021\/acs.inorgchem.8b01979","volume":"57","author":"A Enriquez Garcia","year":"2018","unstructured":"Enriquez Garcia, A., Jalilehvand, F., Niksirat, P., Gelfand, B.S.: Methionine binding to dirhodium (II) tetraacetate. Inorg. Chem. 57(20), 12787\u201312799 (2018). https:\/\/doi.org\/10.1021\/acs.inorgchem.8b01979","journal-title":"Inorg. Chem."},{"issue":"60","key":"5_CR42","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.1039\/c2cc33808d","volume":"48","author":"BV Popp","year":"2012","unstructured":"Popp, B.V., Chen, Z., Ball, Z.T.: Sequence-specific inhibition of a designed metallopeptide catalyst. Chem. Comm. 48(60), 7492\u20137494 (2012). https:\/\/doi.org\/10.1039\/c2cc33808d","journal-title":"Chem. Comm."},{"issue":"39","key":"5_CR43","doi-asserted-by":"publisher","first-page":"10927","DOI":"10.1039\/c1cc13169a","volume":"47","author":"AN Zaykov","year":"2011","unstructured":"Zaykov, A.N., Ball, Z.T.: A general synthesis of dirhodium metallopeptides as MDM2 ligands. Chem. Comm. 47(39), 10927\u201310929 (2011). https:\/\/doi.org\/10.1039\/c1cc13169a","journal-title":"Chem. Comm."},{"issue":"18","key":"5_CR44","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1039\/D2DT00873D","volume":"51","author":"D Loreto","year":"2022","unstructured":"Loreto, D., Esposito, A., Demitri, N., Guaragna, A., Merlino, A.: Digging into protein metalation differences triggered by fluorine containing-dirhodium tetracarboxylate analogues. Dalton Trans. 51(18), 7294\u20137304 (2022). https:\/\/doi.org\/10.1039\/D2DT00873D","journal-title":"Dalton Trans."},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"213999","DOI":"10.1016\/j.ccr.2021.213999","volume":"442","author":"D Loreto","year":"2021","unstructured":"Loreto, D., Merlino, A.: The interaction of rhodium compounds with proteins: a structural overview. Coord. Chem. Rev. 442, 213999 (2021). https:\/\/doi.org\/10.1016\/j.ccr.2021.213999","journal-title":"Coord. Chem. Rev."},{"issue":"1","key":"5_CR46","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1021\/acscatal.8b02615","volume":"9","author":"JA Laureanti","year":"2018","unstructured":"Laureanti, J.A., Buchko, G.W., Katipamula, S., Su, Q., Linehan, J.C., Zadvornyy, O.A., et al.: Protein scaffold activates catalytic CO2 hydrogenation by a rhodium bis (diphosphine) complex. ACS Catal. 9(1), 620\u2013625 (2018). https:\/\/doi.org\/10.1021\/acscatal.8b02615","journal-title":"ACS Catal."},{"key":"5_CR47","doi-asserted-by":"publisher","unstructured":"Panella, L., Broos, J., Jin, J., Fraaije, M.W., Janssen, D.B., Jeronimus-Stratingh, M., et al.: Merging homogeneous catalysis with biocatalysis; papain as hydrogenation catalyst. Chem. Comm. 45, 5656\u20135658 (2005). https:\/\/doi.org\/10.1039\/B512138H","DOI":"10.1039\/B512138H"},{"issue":"8","key":"5_CR48","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1039\/C9DT04819G","volume":"49","author":"G Ferraro","year":"2020","unstructured":"Ferraro, G., Pratesi, A., Messori, L., Merlino, A.: Protein interactions of dirhodium tetraacetate: a structural study. Dalton Trans. 49(8), 2412\u20132416 (2020). https:\/\/doi.org\/10.1039\/C9DT04819G","journal-title":"Dalton Trans."},{"issue":"11\u201312","key":"5_CR49","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ccr.2004.06.016","volume":"248","author":"MA Aquino","year":"2004","unstructured":"Aquino, M.A.: Recent developments in the synthesis and properties of diruthenium tetracarboxylates. Coord. Chem. Rev. 248(11\u201312), 1025\u20131045 (2004). https:\/\/doi.org\/10.1016\/j.ccr.2004.06.016","journal-title":"Coord. Chem. Rev."},{"issue":"12","key":"5_CR50","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1021\/ic300168t","volume":"51","author":"RL Santos","year":"2012","unstructured":"Santos, R.L., van Eldik, R., de Oliveira Silva, D.: Thermodynamics of axial substitution and kinetics of reactions with amino acids for the paddlewheel complex tetrakis (acetato) chloridodiruthenium (II, III). Inorg. Chem. 51(12), 6615\u20136625 (2012). https:\/\/doi.org\/10.1021\/ic300168t","journal-title":"Inorg. Chem."},{"key":"5_CR51","doi-asserted-by":"publisher","unstructured":"Messori, L., Marzo, T., Sanches, R.N.F., de Oliveira Silva, D., Merlino, A.: Unusual structural features in the lysozyme derivative of the tetrakis (acetato) chloridodiruthenium (II, III) complex. Angew. Chem. Int. Ed. 53(24), 6172\u20136175 (2014). doi: https:\/\/doi.org\/10.1002\/anie.201403337","DOI":"10.1002\/anie.201403337"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"120684","DOI":"10.1016\/j.ica.2021.120684","volume":"530","author":"I Tolbatov","year":"2021","unstructured":"Tolbatov, I., Marrone, A.: Reaction of dirhodium and diruthenium paddlewheel tetraacetate complexes with nucleophilic protein sites: a computational study. Inorg. Chim. Acta 530, 120684 (2021). https:\/\/doi.org\/10.1016\/j.ica.2021.120684","journal-title":"Inorg. Chim. Acta"},{"issue":"41","key":"5_CR53","doi-asserted-by":"publisher","first-page":"16421","DOI":"10.1021\/acs.inorgchem.2c02516","volume":"61","author":"I Tolbatov","year":"2022","unstructured":"Tolbatov, I., Marrone, A.: Kinetics of reactions of dirhodium and diruthenium paddlewheel tetraacetate complexes with nucleophilic protein sites: computational insights. Inorg. Chem. 61(41), 16421\u201316429 (2022). https:\/\/doi.org\/10.1021\/acs.inorgchem.2c02516","journal-title":"Inorg. Chem."},{"issue":"8","key":"5_CR54","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1039\/D3QI00157A","volume":"10","author":"I Tolbatov","year":"2023","unstructured":"Tolbatov, I., Barresi, E., Taliani, S., La Mendola, D., Marzo, T., Marrone, A.: Diruthenium (II, III) paddlewheel complexes: effects of bridging and axial ligands on anticancer properties. Inorg. Chem. Front. 10(8), 2226\u20132238 (2023). https:\/\/doi.org\/10.1039\/D3QI00157A","journal-title":"Inorg. Chem. Front."},{"issue":"39","key":"5_CR55","doi-asserted-by":"publisher","first-page":"15664","DOI":"10.1021\/acs.inorgchem.2c02685","volume":"61","author":"I Tolbatov","year":"2022","unstructured":"Tolbatov, I., Storchi, L., Marrone, A.: Structural reshaping of the zinc-finger domain of the SARS-CoV-2 nsp13 protein using bismuth (III) ions: a multilevel computational study. Inorg. Chem. 61(39), 15664\u201315677 (2022). https:\/\/doi.org\/10.1021\/acs.inorgchem.2c02685","journal-title":"Inorg. Chem."},{"issue":"22","key":"5_CR56","doi-asserted-by":"publisher","first-page":"10801","DOI":"10.1021\/acs.inorgchem.5b01832","volume":"54","author":"I Ritacco","year":"2015","unstructured":"Ritacco, I., Russo, N., Sicilia, E.: DFT investigation of the mechanism of action of organoiridium (III) complexes as anticancer agents. Inorg. Chem. 54(22), 10801\u201310810 (2015). https:\/\/doi.org\/10.1021\/acs.inorgchem.5b01832","journal-title":"Inorg. Chem."},{"issue":"20","key":"5_CR57","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1039\/D0DT00923G","volume":"49","author":"S Todisco","year":"2020","unstructured":"Todisco, S., Latronico, M., Gallo, V., Re, N., Marrone, A., Tolbatov, I., et al.: Double addition of phenylacetylene onto the mixed bridge phosphinito\u2013phosphanido Pt (I) complex [(PHCy2)Pt(\u03bc-PCy2){\u03ba2P, O-\u03bc-P(O)Cy2}Pt(PHCy2)](Pt\u2013Pt). Dalton Trans. 49(20), 6776\u20136789 (2020). https:\/\/doi.org\/10.1039\/D0DT00923G","journal-title":"Dalton Trans."},{"key":"5_CR58","unstructured":"Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., et al.: Gaussian 16 Revision C. Gaussian Inc.m Wallingford, CT, USA (2016)"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"120686","DOI":"10.1016\/j.ica.2021.120686","volume":"530","author":"I Tolbatov","year":"2022","unstructured":"Tolbatov, I., Marrone, A.: Computational strategies to model the interaction and the reactivity of biologically-relevant transition metal complexes. Inorg. Chim. Acta 530, 120686 (2022). https:\/\/doi.org\/10.1016\/j.ica.2021.120686","journal-title":"Inorg. Chim. Acta"},{"issue":"4","key":"5_CR60","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/wcms.1178","volume":"4","author":"T Tsuneda","year":"2014","unstructured":"Tsuneda, T., Hirao, K.: Long-range correction for density functional theory. Wiley Interdiscip. Rev. Comput. Mol. Sci. 4(4), 375\u2013390 (2014). https:\/\/doi.org\/10.1002\/wcms.1178","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"issue":"44","key":"5_CR61","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1039\/B810189B","volume":"10","author":"JD Chai","year":"2008","unstructured":"Chai, J.D., Head-Gordon, M.: Long-range corrected hybrid density functionals with damped atom\u2013atom dispersion corrections. Phys. Chem. Chem. Phys. 10(44), 6615\u20136620 (2008). https:\/\/doi.org\/10.1039\/B810189B","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"1","key":"5_CR62","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1021\/acs.inorgchem.1c03608","volume":"61","author":"I Tolbatov","year":"2021","unstructured":"Tolbatov, I., Marrone, A.: Reactivity of N-heterocyclic carbene half-sandwich Ru-, Os-, Rh-, and Ir-based complexes with cysteine and selenocysteine: a computational study. Inorg. Chem. 61(1), 746\u2013754 (2021). https:\/\/doi.org\/10.1021\/acs.inorgchem.1c03608","journal-title":"Inorg. Chem."},{"key":"5_CR63","unstructured":"Dolg, M.: Effective core potentials. In: Grotendorst, J. (Ed.), Modern Methods and Algorithms of Quantum Chemistry, Second Edition, John von Neumann Institute for Computing, Julich, NIC Series, Vol. 3, pp. 507\u2013540 (2000)"},{"key":"5_CR64","doi-asserted-by":"publisher","unstructured":"Paciotti, R., Tolbatov, I., Marrone, A., Storchi, L., Re, N., Coletti, C.: Computational investigations of bioinorganic complexes: the case of calcium, gold and platinum ions. In: AIP Conference Proceedings, vol. 2186, no. 1, pp. 030011:1\u20134. AIP Publishing LLC (2019). https:\/\/doi.org\/10.1063\/1.5137922","DOI":"10.1063\/1.5137922"}],"container-title":["Lecture Notes in Computer Science","Computational Science and Its Applications \u2013 ICCSA 2023"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-36805-9_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T23:04:09Z","timestamp":1688079849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-36805-9_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031368042","9783031368059"],"references-count":64,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-36805-9_5","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"30 June 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"ICCSA","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Conference on Computational Science and Its Applications","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Athens","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Greece","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2023","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"3 July 2023","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"6 July 2023","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"23","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"iccsa2023","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/iccsa.org\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Single-blind","order":1,"name":"type","label":"Type","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"Custom based on Cyberchair 4","order":2,"name":"conference_management_system","label":"Conference Management System","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"283","order":3,"name":"number_of_submissions_sent_for_review","label":"Number of Submissions Sent for Review","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"67","order":4,"name":"number_of_full_papers_accepted","label":"Number of Full Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"13","order":5,"name":"number_of_short_papers_accepted","label":"Number of Short Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"24% - The value is computed by the equation \"Number of Full Papers Accepted \/ Number of Submissions Sent for Review * 100\" and then rounded to a whole number.","order":6,"name":"acceptance_rate_of_full_papers","label":"Acceptance Rate of Full Papers","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"2.5","order":7,"name":"average_number_of_reviews_per_paper","label":"Average Number of Reviews per Paper","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"8,5","order":8,"name":"average_number_of_papers_per_reviewer","label":"Average Number of Papers per Reviewer","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"Yes","order":9,"name":"external_reviewers_involved","label":"External Reviewers Involved","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"PHD Showcase Papers: 6(for main conf) \/ For ICCSA 2023 Workshops 876 subm sent, 350 full papers and 29 short papers accepted, additional PHD Showcase Papers: 2","order":10,"name":"additional_info_on_review_process","label":"Additional Info on Review Process","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}}]}}